While DM, insurance provider, HR and HER2 status, grade, ECE, LVI, and chemotherapy duration significantly influenced the rate of pCR in the univariable analysis, only Ki-67, BMI, and HR status remained significant following adjusted analysis where triple-negative breast cancer (TNBC) was associated with improved outcomes. Here, ERBB2 is linked to triple-negative breast carcinoma.